Class II recall: Baxter Healthcare Corporation: Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL)

Baxter Healthcare Corporation initiated a Class II recall of Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) single-dose infusion bags in 100 mL GALAXY containers, NDC 0338-9648-12. The recall notice cites CGMP deviations as the reason for the action.

Most relevant for: Hospital and inpatient care settings using intravenous pantoprazole for acid suppression, such as in patients with GI bleeding or those unable to take oral medications.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.